Skip to content

Drug interactions

Deferasirox + Ramelteon

Severity: Moderate

Deferasirox and Ramelteon: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Deferasirox inhibits CYP1A2, the main enzyme metabolizing ramelteon, and may substantially raise ramelteon concentrations. This could increase drowsiness, dizziness and next-day impairment.

What this interaction means in plain words

Deferasirox and Ramelteon can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Deferasirox belongs to Miscellaneous; Ramelteon belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Deferasirox inhibits CYP1A2-mediated metabolism of ramelteon.

What to do

Monitor for excessive sedation and consider an alternative hypnotic not dependent on CYP1A2. Avoid driving if drowsy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Ramelteon, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deferasirox with Ramelteon?

MediHelp rates the interaction as moderate. Deferasirox and Ramelteon can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Deferasirox inhibits CYP1A2, the main enzyme metabolizing ramelteon, and may substantially raise ramelteon concentrations. This could increase drowsiness, dizziness and next-day impairment.

How serious is the interaction between Deferasirox and Ramelteon?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for excessive sedation and consider an alternative hypnotic not dependent on CYP1A2. Avoid driving if drowsy.

What other medicines interact with Ramelteon?

MediHelp also lists interactions of Ramelteon with, for example, Calcium / magnesium / potassium / sodium oxybates, Fluvoxamine, Sodium oxybate. The full list is on the Ramelteon page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in